Successful Use of Two Thrombolytic Drugs in Prosthetic Mitral and Aortic Valve Thrombosis
Author(s) -
Shayesteh Gheibi,
Aliasghar Farsavian,
Maryam Nabati,
Gohar Eslami
Publication year - 2020
Publication title -
pharmaceutical and biomedical research
Language(s) - English
Resource type - Journals
eISSN - 2423-4494
pISSN - 2423-4486
DOI - 10.18502/pbr.v5i4.2399
Subject(s) - medicine , streptokinase , thrombosis , prosthesis , surgery , mitral valve replacement , cardiology , complication , mitral valve , mechanical valve , adverse effect , myocardial infarction
Prosthetic valve thrombosis is a rare and severe complication of valve
replacement, most often encountered with a mechanical prosthesis. The significant morbidity
and mortality associated with this condition warrant rapid diagnostic evaluation. Although
surgery is the first-line therapy in symptomatic obstructive mechanical valve thrombosis,
thrombolytic therapy has been used as an alternative.
Case Description: In this case report, we describe a 46-year-old man with a history of the
mitral valve and aortic valve replacement 2 years ago. In echocardiography, we detected a
mobile mass on the atrial side of the mitral valve prosthesis and a fixed one on the leaflet of
the mechanical aortic valve with a high gradient. To save his life, we used double thrombolytic
therapy considering the patient’s hemodynamic situation and the risk of bleeding. Although
a routine dose of reteplase and streptokinase was considered, we administered these two
thrombolytic drugs together within 72 hours.
Conclucsion: Ultimately we succeeded with this method without any significant or life-threatening
adverse effects, and the patient was discharged after an optimal anticoagulation therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom